Company Quick10K Filing
Vitalibis
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 31 $13
10-Q 2019-08-09 Quarter: 2019-06-30
S-1 2019-05-16 Public Filing
10-Q 2019-05-10 Quarter: 2019-03-31
10-K 2019-03-28 Annual: 2018-12-31
10-Q 2018-11-05 Quarter: 2018-09-30
10-Q 2018-08-02 Quarter: 2018-06-30
10-Q 2018-05-11 Quarter: 2018-03-31
10-K 2018-04-10 Annual: 2017-12-31
10-Q 2017-11-13 Quarter: 2017-09-30
10-Q 2017-08-10 Quarter: 2017-06-30
10-Q 2017-05-12 Quarter: 2017-03-31
10-K 2017-03-31 Annual: 2016-12-31
10-Q 2016-11-09 Quarter: 2016-09-30
10-Q 2016-08-08 Quarter: 2016-06-30
10-Q 2016-05-11 Quarter: 2016-03-31
10-K 2016-03-18 Annual: 2015-12-31
10-Q 2015-11-09 Quarter: 2015-09-30
8-K 2019-11-18 Other Events, Exhibits
8-K 2018-11-15 Officers
8-K 2018-03-07 Enter Agreement, Regulation FD, Exhibits
8-K 2018-02-08 Amend Bylaw, Regulation FD, Exhibits
8-K 2018-01-18 Other Events, Exhibits
8-K 2018-01-02 Other Events, Exhibits
8-K 2018-01-02 Other Events

Vitalibis Financials

VCBD Metrics, Comps, Filings

Annual | Quarterly

Business

We are an emerging growth company as defined in Section 2(a)(19) of the Securities Act. We will continue to be an emerging growth company until: (i) the last day of our fiscal year during which we had total annual gross revenues of $1,000,000,000 or more; (ii) the last day of our fiscal year following the fifth anniversary of the date of the first sale of our common stock pursuant to an effective registration statement under the Securities Act; (iii) the date on which we have, during the previous 3-year period, issued more than $1,000,000,000 in non-convertible debt; or (iv) the date on which we are deemed to be a large accelerated filer, as defined in Section 12b-2 of the Exchange Act.

Section 14A (a) and (b) of the Exchange Act, which requires companies to hold stockholder advisory votes on executive compensation and golden parachute compensation;

The requirement to provide in any registration statement periodic report or other report to be filed with the Securities and Exchange Commission, certain modified executive compensation disclosure under Item 402 of Regulation S-K or selected financial data under Item 301 of Regulation S-K for any period before the earliest audited period presented in our initial registration statement;


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
XSport Global (TLLT) 13,108 36% -6.7 -349% 774 4,664 2,009 714 -2,699 -2,077 13,877
Rocky Mountain High Brands (RMHB) 13,078 8% -3.5 227,454,000% 230 19 -2,275 -3,826 13,388
Strategic Environmental & Energy Resources (SENR) 13,014 13% -9.9 -89% 3,018 8,267 6,746 859 -2,678 -1,365 13,486
Gilla (GLLA) 12,944 65% -3.1 -134% 4,303 12,570 4,388 2,873 -5,761 -4,419 13,882
FC Global Realty (FCRE) 12,848 122% 25.1 11% 4,171 4,793 41 50 476 494 12,379
Advanzeon (CHCR) 12,799 59% -12.3 -121% 1,648 28,863 332 197 -1,998 -1,998 24,485
nDivision (NDVN) 12,753 78% -15.9 146,140,300% 1,553 5,158 4,047 -1,461 -795 12,657
Black Box (BBOX) 12,647 27% 57.9 -21% 297,764 237,819 738,286 202,895 -63,375 1,605 92,921
GT Biopharma (GTBP) 12,635 -0.1 -962% 25,707 16,731 0 0 -247,313 -243,434 12,371
LifeApps Brands (LFAP) 12,599 100% -2.3 -1,669% 299 1,770 5 5 -4,991 -5,474 12,348
Vitalibis (VCBD) 12,570 43% -2.7 -1,081% 437 784 225 97 -4,725 -4,722 12,558
Inrad Optics (INRD) 12,425 26% 36.4 1% 7,448 5,102 10,684 2,764 51 318 11,594
ETF Managers Group Commodity Trust I (RISE) 12,354 15.0 5% 16,600 372 0 0 825 825 12,354
Rangeford Resources (RGFR) 12,303 -16.3 -156,832% 1 2,524 0 0 -801 -801 13,102
Tofutti Brands (TOFB) 12,215 29% -128.7 1% 5,327 1,616 12,493 3,653 52 -88 11,322
CannaPowder (CAPD) 12,156 -2.4 -1,041% 471 17 0 0 -4,900 -4,900 11,730
Mymetics (MYMX) 12,150 0% -4.9 -58% 7,529 56,756 609 0 -4,352 -2,344 11,552
Curaegis Technologies (CRGS) 12,127 -63% -4.6 -2,015% 297 10,690 30 -19 -5,984 -4,750 22,051
Integral Technologies (ITKG) 12,094 0% -2.9 -922% 598 5,110 1,086 0 -5,514 -3,983 11,714
Enzon Pharmaceuticals (ENZN) 11,938 0% 1.0 48% 12,403 455 6,999 0 5,970 8,974 8,571

Balance Sheet ($'000)2015-12-312016-12-312017-12-312018-12-312019-03-31
Cash21017261
Accounts Receivable0
Inventory189154
PP&E
Assets610570409
Accounts Payable70
Long-Term Debt
Liabilities8016180236
Stockholders' Equity-740-6390173
Income Statement ($'000)2015-12-312016-12-312017-12-312018-12-312019-03-31
Revenue0051
Cost of Revenue0023
Gross Profit0028
R&D2
SG&A63611032,096
Tax0000
Net Income-63-61-103-2,229
Cash Flow ($'000)2015-12-312016-12-312017-12-312018-12-312019-03-31
Cash Operating-28-31-1-543
Cash Investing-176
Cash Financing10300891